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Background: Environmental enteropathy (EE) is associated with stunting, impairment of 43 
responses to oral vaccines and other adverse health consequences in young children throughout 44 
the developing world. EE is characterised by chronic low-grade intestinal inflammation and 45 
disrupted epithelial-barrier integrity, partly resulting from dysregulation of tight junction 46 
proteins; observed in other enteropathies such as coeliac disease. During EE, this dysregulation 47 
of tight junction expression amplifies translocation of pathogenic bacteria across the intestinal 48 
mucosa.  49 
Aims: Determine if enteropathogen-mediated epithelial-barrier failure can be ameliorated using 50 
contra-pathogenicity therapies.   51 
Methods: Intestinal epithelial-barrier damage was assessed in Caco-2 cells incubated with three 52 
important enteropathogens identified in EE patients: Enteropathogenic Escherichia coli (EPEC), 53 
Citrobacter rodentium (C. rodentium) and Cryptosporidium parvum (C. parvum). Potential 54 
therapeutic molecules were tested to detect effects on transepithelial resistance (TER), bacterial 55 
translocation (BT), claudin-4 expression and regulation of the inflammatory cytokine response.  56 
Results: All three enteropathogens compared to uninfected cells, reduced TER (EPEC; p<0.0001, 57 
C. rodentium; p<0.0001, C. parvum; p<0.0007), reduced claudin-4 expression, and permitted BT 58 
(EPEC; p<0.0001, C. rodentium; p<0.0001, C. parvum; p<0.0003) through the monolayer. Zinc, 59 
colostrum, epidermal growth factor, trefoil factor 3, resistin-like molecule-β, hydrocortisone and 60 
the myosin-light chain kinase (MLCK) inhibitor ML7 (Hexahydro-1-[(5-iodo-1-61 
naphthalenyl)sulfonyl]-1H-1,4-diazepine hydrochloride); ML7) improved TER (up to 70%) and 62 
decreased BT (as much as 96%). Only Zinc demonstrated modest antimicrobial activity.  63 
Conclusion: The enteropathogens impaired intestinal-epithelial barrier-integrity with 64 
dysregulation of claudin-4 and increased bacterial translocation. Enteropathogen-mediated 65 
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damage was reduced using contra-pathogenicity agents which mitigated the effects of pathogens 66 
without direct antimicrobial activity.  67 
 68 
Keywords: Intestinal-barrier, claudin-4, microbial translocation, Enteropathogenic Escherichia 69 
coli, Citrobacter rodentium, Cryptosporidium parvum. 70 




Many disorders of the small intestine are characterised by increased permeability and impaired 73 
barrier function[1]. Environmental enteropathy (EE) is emerging as an example of a small intestinal 74 
disorder induced by frequent, often co-existent, sub-clinical intestinal infections [2,3,4], with or 75 
without nutrient deficiencies. It is associated with stunting and poor growth in young children 76 
throughout the developing world[5], with severe impaired responses to oral vaccines [6], and with 77 
reduced net absorption of micronutrients[7] and some drugs [8]. EE is characterised by chronic 78 
low-grade intestinal inflammation [9] such as lymphocytic infiltration of the lamina propria and 79 
increased intraepithelial lymphocytes, increased translocation of bacteria across the intestinal 80 
mucosa[10], reduced epithelial surface area, and immaturity of the absorptive cells of the 81 
intestine. There is also dysregulation of tight junctions (TJ) located at the apical margins of the 82 
lateral membranes of intestinal epithelial cells, which seal the intercellular space and define the 83 
boundary of the host versus the environment in the intestinal lumen [11]. As this dysregulation 84 
appears, at least partly, to explain microbial translocation [10,11], characterisation of its 85 
mechanisms is critical for improving health of children in low- and middle-income countries 86 
(LMICs) [12] . It may also assist in understanding critical care sepsis, autoimmune and neurological 87 
disorders of the gut. 88 
 89 
Recent major studies, building on decades of observational microbiology, have defined many of 90 
the most important enteropathogens responsible for diarrhoea in children in LMICs [13,14]. Our 91 
understanding of the contribution of enteropathogens to EE is less advanced, but emerging 92 
evidence links the severity of enteropathy (and growth failure) to frequent sub-clinical infections 93 
with parasites, viruses and bacteria [2,15,16]. Those enteropathogens which are invasive or cause 94 
intestinal epithelial disruption have been associated with more severe inflammation and growth 95 
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impairment[17]. The mechanism through which enteropathogens induce enteropathy is unknown, 96 
but in view of the intense microbial translocation found in children and adults with EE, it seems 97 
that impairment of epithelial barrier function [1] is central to pathophysiology. Whether this 98 
impairment is due to impairment of TJ, or to larger defects at sites of epithelial cell shedding, is 99 
unclear. What is known is that shedding of individual intestinal epithelial cells does not lead to 100 
impairment of epithelial barrier function [18], but simultaneous loss of multiple cells does impair 101 
it and may lead to intestinal inflammation.  102 
 103 
In previous work, our group studied adults with EE in Lusaka, Zambia using several methods 104 
including histology and confocal laser endomicroscopy (CLE). We demonstrated that there was 105 
marked epithelial barrier disruption in these EE patients with corresponding epithelial leakage 106 
images visible by CLE [10]. We suggested the epithelial defects were probably sites of bacterial 107 
translocation, and then hypothesised that it might be possible to ameliorate enteropathogen-108 
mediated damage using therapies targeting the epithelium. Here we describe a series of 109 
experiments to test novel therapeutic approaches for reduction of translocation in EE. These 110 
agents were selected from transcriptomic work (Kelly, unpublished observations) and extensive 111 
literature searches looking at their potential to function as either TJ modifiers or selective 112 
enhancers of epithelial barrier function (full explanations are listed in Supplementary Table 1).  113 
 114 
We used an in vitro modelling system with polarised Caco-2 cells and three different 115 
enteropathogens: 1) Enteropathogenic Escherichia coli (EPEC), part of a group of related 116 
pathogens which are an important cause of infant diarrhoea [19] and known to disrupt cell-cell 117 
junctions [20,21]; 2) Citrobacter rodentium (C. rodentium), a natural murine intestinal pathogen 118 
which has also been identified in EE cases of adults (human) in Zambia [22],and Cryptosporidium 119 
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parvum (C. parvum), associated with adverse outcomes in children with malnutrition [14,23]. C. 120 
rodentium possesses a locus of enterocyte effacement (LEE) pathogenicity island that shares all 121 
41 open reading frames with that of EPEC [24]. Therefore, EPEC and C. rodentium share a core set 122 
of virulence factors utilising intimate bacterial attachment to the host cells through attaching and 123 
effacing (A/E) lesions [25,26]. C. parvum infects the intestinal epithelium producing a 124 
parasitophorous vacuole in which the parasite resides in an intracellular yet extra-cytoplasmic 125 
manner [23]. Cryptosporidial enteropathy has recently also been shown to occur in an animal 126 
model [27]. 127 
 128 
Materials and Methods 129 
 130 
Cell culture 131 
The human Caco-2 enterocyte cell line (passage 6-40) was obtained from the American Type 132 
Culture Collection (ATCC: HTB-37; Middlesex, UK) and grown as monolayers (VWR, Leicestershire, 133 
UK) at 37oC in humidified 5% CO2 in complete medium consisting of Dulbecco’s Modified Essential 134 
Medium supplemented with 10% heat-inactivated fetal calf serum (FCS), 4 mM L-glutamine, 135 
100U/ml penicillin, 100g/ml streptomycin and 1% non-essential amino acids (Invitrogen Life 136 
Technologies, Paisley, UK). For membrane integrity and translocation investigations, trypsinised 137 
cells were seeded at a density of 1x 106/ml into 12 well plates holding polyethylene terephthalate 138 
(3.0μm) cell culture inserts (Transwell inserts, Millipore, Hertfordshire, UK), for 139 
immunofluorescence experiments at 5x 105/ml into 24-well culture plates (VWR International, 140 
Leicestershire, UK) with 13mm glass coverslips, or at 2 x 106/ml into 6 well plates for Western 141 
blot experiments. Cells were grown until polarization (15-21 days) for translocation studies or 142 
until 75% confluent for staining experiments (4-5 days; limiting cell damage during staining 143 
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procedure) before experiments were conducted. In some experiments, FCS was withheld from 144 
the medium to model nutrient depletion in malnutrition. Formation and disruption of polarised 145 
monolayers (membrane integrity) was determined by regular measurement of transepithelial 146 
electrical resistance (TER) (Millicell-ERS; Millipore, Livingston, UK). Caco2 cell monolayers were 147 
considered polarised when TER readings reached 800-1000 ohms/cm2 [28] correlating with the up-148 
regulated expression of the brush border enzyme sucrase isomaltase (data not shown). Migration 149 
of Caco2 cells through the filters was not observed in basolateral media. 150 
 151 
Bacterial strains and Parasite  152 
EPEC strain RDEC-1 serotype O15:H7 (ATCC 49106; rabbit) and C. rodentium strain DBS100, 153 
Biotype 4280 (ATCC 51459) were used. A non-pathogenic Escherichia coli K12 (E. coli K12) isolate 154 
was a generous gift from Dr David Wareham (Blizard Institute, Barts and The London School of 155 
Medicine, UK). Fresh colonies were stored on Luria-Bertani (LB) agar at 4°C and grown up in LB 156 
broth (LB agar and broth; Fisher Scientific, Leicestershire, UK) at 37°C overnight for each 157 
experiment. For immunofluorescence experiments, bacteria were incubated with rhodamine B 158 
isothiocyanate (Sigma-Aldrich, Dorset, UK) at 1mg/ml for 2h in the dark with gentle shaking, then 159 
washed. Oocysts of the C. parvum IOWA isolate (Bunch Grass Farm, Deary, ID, USA) were stored 160 
in phosphate buffered saline (PBS) at pH7.2 at 4oC. Prior to use oocysts were surface sterilized in 161 
10% (v/v) sodium hypochlorite (VWR, Leicestershire, UK) and centrifuged at 500xg for 10 min.  162 
 163 
In vitro bacterial and parasite infections 164 
Before infection commenced, monolayers were washed with PBS. Pathogens at 1x106 colony 165 
forming units (CFUs)/well (for 12 well plates) were then added to the brush border face of the 166 
monolayer in 1ml complete medium. C. parvum infection was initiated using 1x106 oocysts in 167 
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250l complete medium with 1x106 CFU/ml/well of non-pathogenic E. coli K12. After 2h at 37oC, 168 
cells were washed to remove oocyst debris and 1ml complete medium with 1x106 CFU/ml/well 169 
of E. coli K12 introduced. Both bacterial and parasite infections developed for 24h without 170 
antibiotics at any stage. For studies using 6- and 24-well plates the numbers of bacteria, parasites 171 
and volumes of medium were scaled up or down accordingly.  172 
 173 
Quantification of transepithelial resistance (TER) and bacterial translocation 174 
Electrical resistance across the stratified epithelium was measured using a Millicell-ERS-2 175 
instrument (Millipore, Bedford, Mass) with tweezer-like electrodes. Before measurement, the 176 
electrodes were equilibrated and sterilized according to the manufacturer’s recommendations. 177 
The value obtained from a blank insert (with culture medium) was subtracted to give the net 178 
sample resistance, which was then multiplied by the membrane area to give the resistance in 179 
area-corrected units (Ω/cm2). TER was measured before and after 24h infections. To observe 180 
bacterial translocation (BT), the medium from the basolateral compartment of the Transwell 181 
insert after infection was cultured for colony quantification. The apicomplexan parasite, C. 182 
parvum, was co-cultured with the non-invasive bacteria Escherichia coli K12 (K12) in the in vitro 183 
model, Therefore, K12 was used as a marker of BT during C. parvum infection. Whereas, for EPEC 184 
and C. rodentium experiments, each bacterium was used as the BT marker 185 
 186 
Fixation of cell monolayers and Immunofluorescence (IF) 187 
Confluent monolayers were fixed for 20min in 4% paraformaldehyde (Room temperature; RT), 188 
washed in PBS, then heated at 95°C for 10min with antigen retrieval buffer (10mM Tris Base, 189 
1mM EDTA, 0.05% Tween, pH 9.5) and washed again in PBS. C. parvum infected cells were 190 
permeabilized with 0.2% Triton X-100 at RT for 3 min then washed in PBS. Cells were blocked 191 
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with 20% goat serum (Abcam, Cambridge, UK) for 30min, incubated with 1:100 rabbit polyclonal 192 
anti-claudin 4 (antibodies from Abcam, Cambridge, UK) in 20% goat serum for 2h at RT, then 193 
washed in PBS and incubated with conjugated secondary antibody (anti-rabbit IgG H & L -194 
AlexaFluor) for 1h at RT. Cells were mounted in Vectorshield including DAPI (Vector Laboratories, 195 
Peterborough, UK). For C. parvum staining, 1μg/ml-1 VVL (lectin of Vicia villosa, Vector 196 
laboratories, Peterborough, UK) in PBS with 1% Bovine serum albumin (BSA) was added to cells 197 
for 1h at RT, washed and incubated with 1μg/ml conjugated streptavidin CY3. After 10min, cells 198 
were mounted with vectorshield and DAPI. A Leica DM5000 upright epifluorescence microscope 199 
was used for images at 400x magnification. A Zeiss LSM710 point scanning confocal microscopy 200 
was used for representative confocal images at 400x magnification. 201 
 202 
Lactate Dehydrogenase (LDH) Assay 203 
To evaluate the extent of intestinal epithelial cell damage after enteropathogen infection, the 204 
LDH assay (Promega, Southampton, UK) was performed on culture medium from cell monolayers 205 
± infection (24h), and analysed according to the manufacturer’s instructions.  206 
 207 
Pharmacological therapies 208 
The potential therapeutic agents optimised and tested are listed in Table 1, and the rationale for 209 
their selection is tabulated in Supplementary Table 1.  210 
 211 
Antimicrobial Assay 212 
To establish the antimicrobial activity of each molecule on the bacteria, EPEC, C. rodentium and 213 
E. coli K12 was grown overnight in LB broth, washed and 1x106 CFU/ml incubated with a molecule 214 
at optimal testing concentrations for 24h at 37°C.  E. coli K12 was co-incubated with C. parvum. 215 
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After the incubation period, the samples were cultured on LB agar and bacterial colonies 216 
enumerated.  217 
 218 
Western blotting 219 
Proteins for western blotting were extracted using lysis buffer (Cell RIPA lysis plus protease 220 
inhibitor cocktail, Sigma-Aldrich, Dorset, UK) and sonicated (100W, 10s; Microson, New York, 221 
USA), then centrifuged (13000xg, 10min, 4°C). Total protein (20μg) was boiled at 95-100°C for 5 222 
min, cooled on ice before electrophoresis on 12% SDS-Tris-Glycine gels and then transferred to a 223 
Polyvinylidene fluoride (PVDF) membrane (Amersham Biosciences, Bucks, UK). After overnight 224 
rabbit polyclonal claudin-4 Ab (1:1000) incubation (4°C), the membrane was washed repeatedly 225 
in tris-buffer saline (TBS) and then incubated for 1h with horseradish peroxidase (HRP; 1:10; 226 
Supersignal West Pico rabbit kit (Pierce Fast; Thermo Scientific, Loughborough). Recombinant 227 
human claudin-4 was used as a positive control. To confirm equal protein loading, the membrane 228 
was stripped and Re-Blot plus strong solution (Millipore, Livingston, UK) was added for 20min. 229 
After washes in TBS, the membrane was incubated at 4°C with anti-human GAPDH (1:5000 230 
dilution, Sigma-Aldrich, Dorset, UK) for 1hr and re-developed.  231 
 232 
Cytokine and Chemokine expression assay (Takeda) 233 
Cell supernatants were assessed for cytokine and chemokine expression using the V-PLEX pro-234 
inflammatory panel 1 human assay (Meso Scale Discovery MD, USA). The assay was performed 235 
according to the manufacturer’s instruction.  236 
 237 
Data analysis  238 
TER is presented without transformation whilst bacterial translocation is presented as log colony-239 
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forming units/ml. TER % change was calculated by using the mean decrease due to each 240 
enteropathogen. The Wilcoxon signed-rank test was used to test the effect of the intervention 241 
on paired data from each experiment conducted on adjacent wells, with or without the therapy. 242 
One-way ANOVA with Kruskal-Wallis/Tukey’s post hoc was used for antimicrobial activity, LDH, 243 
bacterial invasion and adherence experiments and cytokine analysis where appropriate. 244 
Statistical significance was established at p<0.05. 245 
 246 





Selected pathogens induce barrier dysfunction in Caco2 cell  250 
In preliminary experiments, an appropriate TER (Ω/cm2) was selected for Caco2 cells to confirm 251 
polarity, which correlated with the expression of the bush border enzyme sucrase isomaltase 252 
(data not shown). All three enteropathogens reduced TER irrespective of nutrient rich or nutrient 253 
deplete conditions (Figure 1A). Both bacterial pathogens elicited a greater decline in TER than C. 254 
parvum whilst non-pathogenic E. coli K12 alone did not modify the TER readings.  EPEC and C. 255 
rodentium added to the apical sides of the intestinal monolayer were isolated and cultured from 256 
the basal Transwell chamber signifying bacterial translocation (BT) had occurred across the 257 
epithelium (Figure 1B). Consistent with observations of TER, there was no BT during incubation 258 
of E. coli K12 alone in the in vitro model, but this was induced by co-culture with C. parvum. 259 
 260 
To confirm that human Caco2 cells were infected by C. rodentium (murine; DBS100), EPEC (rabbit; 261 
RDEC-1) and C. parvum + E. coli K12 (human; K12), adherence and invasion (gentamicin) assays 262 
were performed (Supplementary Figure 1A and B). Previous studies have reported that both 263 
animal and human EPEC strains are clonally related [29], and regardless of the isolate’s original 264 
host, colonisation is similar and so not host dependent [30]. This study has confirmed those key 265 
observations by demonstrating the ability of EPEC (RDEC-1) to attach to the human intestinal 266 
epithelial cells from 30min onwards (P<0.05; Supplementary Figure 1A) and were isolated from 267 
inside Caco2 cells after 60min (P<0.05; Supplementary Figure 1B). The murine pathogen C. 268 
rodentium, also infected Caco2 cells but took longer to attach (60min) and were isolated from 269 
within the cell monolayer at 120min. E. coli K12 when co-cultured with C. parvum, attached and 270 
were isolated from within Caco2 cells over a similar timescale to C. rodentium but in much lower 271 
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numbers. The results confirmed the pathogenicity of the three enteropathogens in Caco2 cells 272 
and indicated that C. parvum may induce paracellular translocation of E. coli K12 whilst EPEC and 273 
C. rodentium appeared to demonstrate partial transcellular movement. 274 
 275 
Barrier dysfunction was associated with reduced claudin-4 276 
Our group has previously shown dysregulation of claudin-4 in biopsies from adults and children 277 
with EE [10,31]. To establish if enteropathogen-induced barrier disruption was also accompanied 278 
by impairment of claudin-4 expression, immunofluorescence and Western blotting of the protein 279 
was performed. In monolayers infected with either of the three enteropathogens, the expression 280 
of claudin-4 (green) was reduced (Figure 2A and B), and this was confirmed by Western blotting 281 
(Figure 2C) and densitometry (Figure 2D). Interestingly, unlike EPEC and C. parvum infections, at 282 
the site of C. rodentium infection the claudin-4 protein appeared to aggregate around the 283 
bacterium, with reduced expression over the remaining cells in the monolayer (Figure 2A). 284 
Although, the LDH assay showed a small increase in Caco2 cell lysis after enteropathogen-285 
infection this was not statistically significant compared to non-infected controls and therefore is 286 
unlikely to explain the loss of claudin-4 expression (Figure 2D). Consistent with TER findings 287 
(Figure 1A), the results show bacterial infections elicited greater reductions of claudin-4 than C. 288 
parvum infection.  289 
 290 
Partial reversal of pathogen-induced barrier dysfunction using contra-pathogenicity agents 291 
Several molecules were screened for their ability to limit the enteropathogen-induced damage 292 
caused to the epithelial barrier integrity (Table 1 and Supplementary table 1). Seven of these 293 
agents: zinc, colostrum, human epidermal growth factor (hEGF), trefoil factor-3 (TFF3), resistin-294 
like molecule-beta (RELM-), hydrocortisone and the myosin-like chain kinase (MLCK) inhibitor 295 
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ML7 (Hexahydro-1-[(5-iodo-1-naphthalenyl)sulfonyl]-1H-1,4-diazepine-hydrochloride); ML7),  296 
impeded the pathogen-induced decrease in TER (Figure 3A) and they also reduced BT (Figure 3B), 297 
suggesting a relationship between these two processes. Vitamin A and leptin had minimal effect 298 
on pathogen-induced damage. Interestingly, to determine the dependence of the molecules on 299 
nutrients, Caco2 cells were starved of fetal calf serum (FCS) which crudely mimics clinical 300 
malnutrition. Nutrient-rich conditions improved TER readings in cells treated with, TFF3, 301 
hydrocortisone, hEGF, zinc and ML7. Colostrum, ML7 (in C. parvum only) and Relm-β, had a 302 
greater effect in nutrient-deplete conditions. To determine whether the nine molecules acted on 303 
the enteropathogens in an antimicrobial manner we incubated these molecules directly with the 304 
pathogens, and no antimicrobial activity was observed except with zinc (Figure 4). Tissue inhibitor 305 
of metalloproteinases (TIMP) 1 and 2 were tested along with low minimum inhibitory 306 
concentrations (MICs) of tetracycline and doxycycline (known to also function as 307 
metalloproteinase inhibitors). However, data are not included due to the strong antimicrobial 308 
activity observed with these widely used antibiotics. 309 
 310 
Two of the most effective contra-pathogenic agents TFF3 and ML7, were further evaluated by 311 
investigating their effect on expression of claudin-4. Both molecules ameliorated the pathogen-312 
induced reduction of claudin-4 protein expression (Figure 5A and C). The Western blot results 313 
were confirmed by densitometry (Figure 5B and D), correlating with observations that both 314 
molecules decreased LDH release from cells induced by enteropathogens infections (Figure 5E). 315 
Although the LDH readings after infection from either of the three enteropathogens was already 316 
low (Figure 2E and Figure 5E), ML7 appeared to block LDH release completely from the three 317 
enteropathogen-infected Caco2 cells (p<0.0001). However, TFF3 appeared slightly more effective 318 
in reducing LDH levels in EPEC-infected cells (p<0.0001) compared to C. rodentium (P<0.007) and 319 
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C. parvum (p<0.007) – infected monolayers.  320 
 321 
A dose-response relationship was apparent for TFF3 (Figure 6), which was also dependent on 322 
nutrient availability. TFF3 increased TER and reduced BT in both nutrient-rich and nutrient-323 
depleted conditions for both EPEC (Figure 6A and B,) and C. rodentium (Figure 6C and D). The 324 
concentration-dependence of TFF3 was clearer in C. rodentium infection, and translocation was 325 
reduced further in the presence of FCS (Fig 6A and C) than in its absence (Fig 6B and D). These 326 
dose-response experiments also demonstrated the marked inverse correlation between TER and 327 
BT (EPEC:  = -0.80, P<0.0001; C. rodentium:  = -0.66, P<0.0001). 328 
 329 
TFF3 and Relm-β increase immune-regulation in enterocytes 330 
The disruption of intestinal barrier function and the alteration of the TJ protein claudin-4 331 
following infection, led us to additionally examine the effect of two goblet cell released contra-332 
pathogenic molecules, TFF3 and Relm-β, in regulating the inflammatory response. The effects of 333 
TTF3 or Relm-β on cytokine release by enteropathogens in polarised Caco2 cells over 24h was 334 
determined by measuring cytokines in supernatants by ELISA. TFF3 and Relm-β modestly 335 
increased the induction of interleukin 10 (IL-10) and tumour necrosis factor alpha (TNF-α) by EPEC 336 
(Figure 7). Relm-β also increased induction of IL-2 and IL-6 by all three pathogens and induced 337 




Several investigators have shown that EPEC [32], C. rodentium [33] and C. parvum [34] infections of 342 
intestinal epithelial monolayers alter barrier function. Using a similar in vitro model, we have tried 343 
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to model the epithelial barrier dysfunction in environmental enteropathy (EE) utilising these 344 
important enteropathogens. We have demonstrated that all three pathogens reduced intestinal 345 
epithelial integrity by decreasing TER associated with downregulation of claudin-4. This barrier 346 
defect could be prevented by agents that mitigated pathogenic effects including the reduction of 347 
bacterial translocation. We refer to this mechanism as a contra-pathogenicity effect as it occurs 348 
without demonstrable antimicrobial activity (except for zinc) and therefore appears to alter the 349 
balance between host and pathogen. There was a clear inverse correlation between membrane 350 
integrity (TER) and BT although details of the mechanism(s) involved require further work. The 351 
contra-pathogenicity effect seems to entail protection against cytopathic effects and tight junction 352 
disruption and reduced ionic conductance. 353 
 354 
The rabbit EPEC strain, RDEC-1, has extensively been used over the years to study the human EPEC 355 
infection because it contains a homolog of the human EPEC 35kb LEE locus (locus of enterocyte 356 
effacement), which encodes all necessary determinants for the (A/E) phenotype[35]. Previous 357 
studies have shown human and rabbit EPEC strains cause A/E lesions in infant pigs indicating EPEC 358 
colonisation is not host-dependent[30] and supports our data.  Sharing a genetically similar LEE 359 
pathogenicity island is the pathogen C. rodentium; the causative agent of transmissible murine 360 
colonic hyperplasia, a naturally occurring disease in laboratory mice [36]. The protozoan parasite C. 361 
parvum causes cryptosporidiosis[37] and has been listed as one of the four major enteric pathogens 362 
causing life-threatening diarrhoea in infants globally[3,13]. Importantly, for our investigation all three 363 
enteropathogens have been isolated in EE patients (both adults and children) in Zambia [22,23,24] and 364 
when used in our in vitro model have been shown to infect Caco2 cells (See supplementary Figure 365 




Previous in vitro studies have observed that EPEC-induced barrier dysfunction is attributed in part 368 
to the secretion of the effector protein, EspF [38] within the first 24hr of infection and not at later 369 
time-points[21]. The mechanism by which EspF expression disrupts the TJ barrier has been correlated 370 
with the redistribution of occludin[38]. Our study now demonstrates the TJ protein, claudin-4, is also 371 
affected within the first 24hr of EPEC infection. Other effector molecules such as EspG1 and EspG2 372 
(involved in microtubule destruction) cause TJ perturbation but claudin-4 localisation has not been 373 
shown to be affected[39]. Unsurprising, C. rodentium also increased intestinal epithelial permeability 374 
in our in vitro model which correlated with claudin-4 disruption. It has been previously reported 375 
that claudin-4 expression was downregulated during C. rodentium infection of the murine cell line 376 
CMT-93, due to the Rho-Rho kinase (ROCK) signalling pathway[33] . However, this mechanism has 377 
not been determined in our model. In agreement with our investigation, the third enteropathogen 378 
tested, C. parvum has been shown to decrease protein levels of claudin-4 in Caco2 cells, mouse 379 
enteroid-derived monolayers and the ileal and jejunal mucosa of mice post- 24hr infection[37]. 380 
Kumar et al., (2018) observed that in Caco2 cells the parasite had no effect on mRNA levels of 381 
claudin-4, whereas both mRNA and protein levels were decreased in vivo (murine and enteroids) 382 
models.  This suggested posttranslational mechanisms, play a role in C. parvum-induced modulation 383 
of claudin-4. Cell death would also reduce claudin-4 expression and increase bacterial translocation 384 
although our lactate dehydrogenase assay findings (Figure 2E) demonstrated this was not a 385 
significant factor. 386 
 387 
Two of the agents we selected for testing (Figure 3) are micronutrients (Vitamin A and Zinc) which 388 
are well known to have protective or therapeutic effects in reducing diarrhoea incidence or 389 
severity[40,41]. ML7 is a small molecule inhibitor of Myosin Light Chain Kinase (MLCK) which has been 390 
implicated in TJ remodelling[42]. Leptin is a hormone postulated to have effects in intestinal 391 
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resistance to infection[43]. Whilst, the remaining five are paracrine mediators of mucosal healing, or 392 
nutrient solutions such as colostrum which are likely to contain them. Vitamin A and leptin had very 393 
little effect at the concentrations and in the preparations used. Among the other active agents, 394 
there was considerable variation in nutrient dependence: hydrocortisone seems to have greater 395 
efficacy under nutrient-deplete conditions, whereas colostrum, hEGF and TFF3 seem to be more 396 
effective in nutrient replete states. Zinc deficiency is known to result in epithelial barrier leak in the 397 
intestines and alter TJ composition[44]. We found zinc improved TER readings and decreased BT. Its 398 
effect on translocation was proportionately greater in C. parvum infection than in bacterial 399 
infections (EPEC and C. rodentium). Interestingly, this effect was nutrient-independent. These 400 
findings are in line with previous studies which showed zinc had a protective effect in pigs suffering 401 
from enterotoxigenic Escherichia coli (ETEC) infections as zinc supplementation prevented or 402 
alleviated diarrhoea in this model [45].  403 
 404 
It appeared that the contra-pathogenicity agents tested varied in effect and this is likely to reflect 405 
variation in cellular receptors or targets. Retinoids act through nuclear receptors. Whilst, Relm-β is 406 
exclusively found in goblet cells of the intestines and may play a role during colonisation and 407 
infection of the gastrointestinal tract[46]. It plays a role in the production of Th2 cytokines during 408 
nematode infections in mice and is essential in helminth expulsion[47]. Relm-β also has been shown 409 
to be induced during C. rodentium infection, in which it is involved in recruiting CD4+ T-cells[48]. TFF3 410 
is also a goblet cell product with well-established protective effects on the small intestinal 411 
mucosa[49] working at the cell membrane. ML7 acts on the adenosine triphosphate- binding site of 412 
the active centre of MLCK causing inhibition[42] and therefore will perform throughout the cell. The 413 
agents which had the greatest effect on translocation, such as TFF3 and ML7, also reduced the 414 
effect of pathogens on claudin-4 expression (Figure 5). With TFF3 demonstrating its action in a dose-415 
20 
 
dependent manner (Figure 6). 416 
 417 
Despite the absence of lymphoid cells in this model we were still able to detect low levels of 418 
cytokine and chemokine secretion, except for IL-8 which was in the range reported by Sansonetti 419 
et al., (1999). The significance of these immunological results is unclear at present. It is possible that 420 
the enteropathogens disrupt claudin-4 distribution and inhibit its restoration and so the contra-421 
pathogenicity molecules may act by modulating the inflammatory response preventing complete 422 
claudin-4 obliteration. Further investigations are needed to understand the cytokine results and to 423 
establish if these therapies involve dual actions, working on both the pathogen and by controlling 424 
the release of the inflammatory mediators which if in excess could be detrimental to host health.  425 
 426 
Given the emergence of antimicrobial resistance as a global phenomenon, development of 427 
strategies to reduce the impact of pathogens on the host intestinal mucosa could be helpful. Some 428 
of the agents we studied are in clinical use, could be easily applied to clinical studies or inserted 429 
into clinical trials. 430 
 431 
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Pharmacological therapies. 619 
Therapy Concentration(s) tested Incubation Time Reference 




Added to Caco2 cells at  
same time as infection 
51 
Human epidermal growth factor (EGF) 100 & 200 ng/ml 52,53 
Hydrocortisone 20,30 & 50μg/ml 54 
Resistin-like molecule β (RELMβ) 100nM 58 
preliminary  
unpublished data 
Trefoil Factor 3 (TFF3) 10ng/well 59 
Colostrum + hEGF 
+TFF3 
Colostrum – 160mg/ml 
hEGF – 200ng/ml 
TFF3 – 10ng 
51,54,55 
Vitamin A (Retinoic acid) 1, 10 & 100 μmol 60 
Leptin 10μM Pre-treated Caco2 cells  
30mins prior infection 
55,56 
Myosin-light chain kinase (MLCK) 
inhibitor ML-7 
50μM Pre-treated Caco2 cells 2h 
prior infection 
32, 57 
Zinc 50 & 100μM Pre-treated Caco2 cells 
24h  or 7days prior 
infection 
61,62 
Table 1: Therapeutic molecules tested including concentrations used and incubation conditions. 620 
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Figure Legends 621 
Figure 1: Selected enteropathogens modulate barrier integrity leading to bacterial 622 
translocation in vitro.  Polarised Caco2 cells grown on Transwell inserts were infected with 623 
Enteropathogenic Escherichia coli (EPEC), Citrobacter rodentium (C. rodentium), Cryptosporidium 624 
parvum (C. parvum) or Escherichia coli K12 for 24h, with or without fetal calf serum (FCS) to model 625 
nutrient-rich or nutrient-deplete conditions respectively. During the C. parvum incubations, 626 
addition of Escherichia coli K12 (K12) was used as a marker of passive translocation. (A) Trans-627 
epithelial resistance (TER) was measured to establish membrane integrity; n=50. One-way 628 
ANOVA with the Kruskal-Wallis test was performed separately for each stimulus with or without 629 
(w/o) FCS. Non-infected Caco2 cells (no infection) was used as the control and compared to each 630 
pathogen dataset: ****p<0.000.1, *** p=0.0007 and ns= non-significant. (B) Basal media from 631 
beneath the monolayer of Caco2 cells (Transwell inserts) were cultured to measure bacterial 632 
translocation (CFU/ml) from the in vitro model; n=50.  One-way ANOVA with the Kruskal-Wallis 633 
test was performed separately on samples with or without (w/o) FCS. Caco2 cells with no 634 
infection were used as the control and compared to the datasets of each pathogen: *** 635 
p=0.0003, ****p<0.0001, , ns = non-significant. 636 
 637 
Figure 2: Enteropathogens dysregulate the expression of the tight junction protein, Claudin-4. 638 
(A) Enteropathogenic Escherichia coli (EPEC), Citrobacter rodentium (C. rodentium) or 639 
Cryptosporidium parvum (C. parvum) were added to non-polarised Caco2 cells grown on 640 
coverslips for 24h. Cells were then fixed, and immunofluorescence staining for claudin-4 (green) 641 
performed. Bacteria (red) were labelled with rhodamine B isothiocyanate (588nm) whilst C. 642 
parvum was identified using the lectin VVL-biotin and CY3-streptavidin (red; 565nm). Cell nuclei 643 
(blue) were stained using DAPI (405nm). Composite images are shown, and scale bars represent 644 
31 
 
100m. (B) A representative confocal image of EPEC infection in Caco2 cells; solid arrows indicate 645 
bacterial colonies and the dotted arrow highlights interruption of Claudin-4 expression. (C) 646 
Western blotting of Claudin-4 protein expression (22kDa) in cells infected for 24h. A positive 647 
control of recombinant claudin-4 (49kDa) was used with levels of GAPDH (36kDa) used to confirm 648 
equal protein loading. D) densitometry confirmed the Western blotting *p<0.005 E) LDH assay 649 
on supernatants of infected monolayers confirmed non-significant (ns) cell lysis compared to the 650 
control (non-infected Caco2 cells). n=24. 651 
 652 
Figure 3: Selected pharmacological agents impede enteropathogen-induced barrier damage 653 
and subsequent bacterial translocation. (A) Transepithelial resistance (TER) of polarised Caco2 654 
cells was measured after 24h infection with Enteropathogenic Escherichia coli (EPEC), Citrobacter 655 
rodentium (C. rodentium) and Cryptosporidium parvum (C. parvum) together with Escherichia coli 656 
K12, in the presence or absence of one of a range of potential therapeutic molecules. 24h prior 657 
to infection Caco2 cells were incubated with or without fetal calf serum (FCS) to model nutrient-658 
rich or nutrient-deplete conditions respectively. The TER results are presented as a percentage 659 
change from Caco2 cells infected with each specific enteropathogen and no molecule. The Mann-660 
Whitney U-test was performed to compare differences between nutrient deplete and nutrient 661 
replete conditions; n=6, *p<0.05, **p<0.005 (B) Bacterial isolation (CFU/ml) from the basal 662 
medium beneath Caco2 cell monolayers (Transwell inserts) was measured to demonstrate 663 
bacterial translocation. CFU results are presented as a percentage change from Caco2 cells 664 
infected with the pathogen alone and without a molecule. Differences between nutrient deplete 665 





Figure 4: The contra-pathogenic molecules have limited antimicrobial activity. The 669 
enteropathogens A) EPEC, B) C. rodentium and C) C. parvum + E. coli K12 were incubated with 670 
each potential therapeutic molecule for 24h and cultured, to establish direct killing effects of the 671 
molecules on the bacteria and presented as CFU/ml [Log10]. The Mann-Whitney U-test was 672 
performed to compare each dataset with each pathogen(s) incubated in medium alone (control). 673 
n= 4; *p<0.02. 674 
 675 
Figure 5:  Trefoil factor-3 (TFF3) and the MLCK inhibitor ML-7, ameliorate dysregulation of 676 
Claudin-4 expression after enteropathogen infection. (A) TFF3 and (C) ML-7 were added to 677 
polarised Caco2 cells prior to infection with Enteropathogenic Escherichia coli (EPEC), Citrobacter 678 
rodentium (C. rodentium) or Cryptosporidium parvum (C. parvum). After 24h, cells were lysed to 679 
measure protein levels of Claudin-4 (22kDa) by Western blotting, with recombinant claudin-4 680 
(49kDa) used as a positive control. Levels of GAPDH (36kDa) were also determined to confirm 681 
equal protein loading. B) TFF3 and D) ML7, represent densitometry of the Western blots *p<0.05, 682 
**P<0.005, ****P<0.0001. E) supernatants of infected monolayers co-stimulated with TFF3 or 683 
ML7 were tested for cell cytotoxicity using the LDH assay and compared with controls (infection 684 
+ no molecule) using One-way ANOVA with the Kruskal-Wallis test.  n=12; *p<0.05, **p<0.005, 685 
***p<0.005.  686 
 687 
Figure 6: TFF3 improves transepithelial resistance and reduces bacterial translocation in a dose-688 
dependent manner, demonstrating the reciprocal relationship between them. Transepithelial 689 
resistance (TER) and bacterial translocation (BT; CFU/ml) were measured in experiments with 690 
varying concentrations of TFF3 during Enteropathogenic Escherichia coli (EPEC; A and B) and 691 
Citrobacter rodentium (CR; C and D) infections for 24h. The experiments were conducted in the 692 
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presence (A and C) or absence (B and D) of fetal calf serum (FCS) to model nutrient-rich or 693 
nutrient-deplete conditions respectively. TFF3 concentrations were 0ng/ml (red), 5ng/ml (green), 694 
10ng/ml (blue) or 20ng/ml (brown). Spearman’s rank correlation coefficient demonstrates  = -695 
0.80 (P<0.0001) for EPEC and  = -0.66 (P<0.0001) for C. rodentium.  696 
 697 
Figure 7: Trefoil factor-3 (TFF3) and Relm-β increase both pro- and anti-inflammatory cytokine 698 
production. Polarised Caco2 cells were infected with: Enteropathogenic Escherichia coli (EPEC), 699 
Citrobacter rodentium (CR) and Cryptosporidium parvum (CP) and co-stimulated with TFF3 or 700 
Relm-β for 24h in nutrient (FCS) deprived conditions. The supernatant from the cells were used 701 
to measure a range of cytokines and chemokines. n=6. One-way ANOVA with Tukey’s post hoc 702 




Supplementary Material 705 
Therapy Rationale Reference 
Colostrum The first milk produced after birth, rich in bioactive molecules including growth 
factors. Colostral fractions or individual peptides present in colostrum have been 
shown to be beneficial in the treatment of gastrointestinal conditions such as 







A component of human colostrum (200μg/L) and milk (30-50μg/L). EGF receptors 
are present on the basolateral membrane of enterocytes. Luminal EGF may gain 
access to the basolateral receptors in the immature neonatal gut due to increased 




Hydrocortisone The glucocorticoid hydrocortisone is present in breast milk. It has anti-
inflammatory properties in both rat and human studies, has been shown to 
regulate the expression of genes involved in development of cell polarity, tight 
junction formation and interactions with extracellular matrices and so may assist 




Leptin Leptin is an adipose-tissue derived hormone that functions in maintaining 
homeostatic control of adipose tissue mass and so its levels fall during starvation. 
Leptin exerts pleiotropic effects on the intestinal epithelium including nutrient 
absorption, epithelial growth, inflammation and injury. It contributes to the 
defence against intestinal amoebiasis. Therefore, leptin could protect the 






MLCK induces contraction of the peri-junctional actomyosin ring through myosin II 
regulatory light chain phosphorylation which regulates tight junction permeability. 
EPEC infection has been shown to induce phosphorylation of the 20 kilodalton 





intestinal barrier function, contributing to the diarrhoea associated with the 
infection. However, Inhibition of the MLC20 phosphorylation prevented EPEC 
induced changes to the epithelium. Therefore, ML-7 could be a class of targeted 




Resistin-like molecule (RELM) beta is secreted by goblets cells in the intestine and 
are essential for normal spontaneous expulsion and IL-4-induced expulsion of 
parasitic helminths, which live in the intestinal lumen but not in IECs.  It is strongly 
induced within goblet cells during C. rodentium infection. It appears also to act as 
a CD4+T cell chemoattractant in the colon, in part via the induction of increased 
IEC proliferation. Therefore, the molecule could induce an immunomodulatory 
response towards the enteropathogens, maintaining epithelial barrier integrity.  
46,47,58 
Trefoil Factor 3 
(TFF3) 
Trefoil peptides are also present in breast milk and in goblet cells along the 
intestinal tract. Goblet cells are depleted during infection with C. rodentium and 
EPEC which results in dramatically reduced TFF3 levels.  TFF3 has been shown to 
down-regulate cytokines (IL-8 & IL-6) and promote the expression of the 
antimicrobial peptides, beta defensin (hBD2&4) in enterocytes. They have been 
shown to be activated in intestinal cells through protease activated receptors 2 
(PAR-2) and so increased TFF3 levels during enteropathogen infections may 





Vitamin A and its analogs are essential for normal development.  Vitamin A 
deficiency (VAD) is associated with decreased immune response and increased 
bacterial translocation and mortality e.g. the retinoic acid (RA) receptor α (RARα) 
signaling in intestinal epithelial cells (IECs) deregulates epithelial lineage 
specification, leading to reduced luminal bacterial detection (for C. rodentium). 
Therefore, increases in Vitamin A exposure could reduce bacterial translocation 
60 
Zinc Zinc is an essential nutrient. Its deficiency is known to result in epithelial barrier 






effect in pigs suffering from enterotoxigenic Escherichia coli (ETEC) infections. This 
observation may be extended to enteropathogens-induced epithelial damage. 
Supplementary Table 1: Molecules tested and rationale for selection 706 
 707 
Assessment of Bacterial Adherence 708 
Cells grown on coverslips were infected with EPEC, C. rodentium or C. parvum + E. coli K12 for 0, 709 
15, 30, 60 and 120min. Medium was then removed, cells washed with PBS and fixed in methanol 710 
(VWR, Leicestershire, UK) for 15min followed by overnight Giemsa (VWR, Leicestershire, UK) 711 
staining. Numbers of cells and bacteria were counted at x200 magnification in 20 randomly 712 
selected fields under a Leica DM500 upright Epi-fluorescent Dual Camera. 713 
 714 
Bacterial Invasion Assay 715 
Cells were infected on the apical side with EPEC, C. rodentium or C. parvum + E. coli K12, for 0, 716 
15, 30, 60 or 120min. Cells were washed in culture media and incubated with gentamicin 717 
(200ug/ml) for 60min to kill extracellular bacteria. Cells were washed three times and lysed in 718 
10mM Tris-HCL pH7.5, 1mM EDTA, and 1% Triton-X (Sigma-Aldrich Company Ltd, Dorset, UK) 719 
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* p < 0.05
** p = 0.0061
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Supplementary Figure 1: EPEC (rabbit), C. rodentium (murine) and C. parvum + E. coli K12 732 
(human) attach and infect Caco2 cells. Enteropathogenic Escherichia coli (EPEC), Citrobacter 733 
rodentium (C. rodentium) or Cryptosporidium parvum (C. parvum) together with Escherichia coli 734 
K12 (K12) were incubated with Caco2 cell monolayers for 0, 15, 30, 60 and 120min. Cells were 735 
washed and underwent Giemsa staining a) The number of bacteria attached per cell was then 736 
enumerated in 20 fields for the adhesion assay b) infected cells were treated with gentamicin for 737 
1h to kill only the extracellular pathogens. The Caco2 cells counted then lysed and cultured on 738 
38 
 
Luria-Bertani (LB) agar plates to enumerate the number of viable intracellular bacteria per Caco2 739 
cell over the time course. Statistical testing using One-way ANOVA with the Kruskal-Wallis test 740 
was used to compare the infections with the no-infection control at each time point; *P<0.05, 741 
**p=0.006. 742 
